Implementation of Transcranial Magnetic Stimulation for Smoking Cessation
NCT: NCT06346028 · RECRUITING
Brief Summary
Repetitive transcranial magnetic stimulation (rTMS) is an alternative non-invasive treatment to help people quit smoking. rTMS uses a magnetic field to stimulate regions of the brain that are involved in addiction. The two brain regions that are stimulated are the insula and the dorsolateral prefrontal cortex, which are involved in drug craving and decision-making, respectively. The goal of this clinical trial is to learn more about the feasibility of offering rTMS as a treatment in the Nicotine Dependence Clinic (NDC) to help daily smokers to quit smoking. The NDC is at the Center for Addiction and Mental Health (CAMH) at 1025 Queen Street West, in Toronto, Canada. Participants will be asked to come to CAMH to: * Complete surveys and optional interviews to learn more about their opinions and experiences with this treatment * Start a treatment course that includes 3 weeks of daily (Monday to Friday) rTMS sessions followed by 3 weeks of weekly rTMS sessions for a total of 6 weeks. Each session lasts about 25 minutes and is provided by an rTMS technician with medical supervision. Objectives • Learning about the feasibility of rTMS as a treatment option for patients in the NDC will help us improve the treatment when offering it in other clinics, which may help improve smoking quit rates and people's overall health.
Frequently Asked Questions
What is Implementation of Transcranial Magnetic Stimulation for Smoking Cessation?
Implementation of Transcranial Magnetic Stimulation for Smoking Cessation is a clinical trial registered under NCT06346028. Current status: RECRUITING.
What is the status of NCT06346028?
The current status of NCT06346028 (Implementation of Transcranial Magnetic Stimulation for Smoking Cessation) is: RECRUITING.
When did Implementation of Transcranial Magnetic Stimulation for Smoking Cessation start?
Implementation of Transcranial Magnetic Stimulation for Smoking Cessation started on 2024-03-30.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.